BioTime (BTX) Misses Q3 EPS by 3c

BioTime (NYSE: BTX) reported Q3 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.7 million, versus $1.5 million reported last year.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• SailPoint Technologies Holdings (SAIL) Tops Q2 EPS by 1c, Offers Guidance
• McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance